Authors
Latest:
How 3PLs Can Up Their Pharma GameThe growing complexity and demand in distribution amid the pandemic present unique technology opportunities for third-party logistics providers
Latest:
COVID-19 Vaccine Distribution SystemDelivering COVID-19 vaccines to 7.8 billion people was a daunting challenge that stretched supply chains past their limits. This white paper dives into vaccine distribution plans and what vaccine manufacturers, distributors and administrators can take away from this monumental time in both the industry and history. Learn how temperature indicators and monitoring solutions played an essential role in the administration of the COVID-19 vaccine.
Latest:
Harnessing the Potential of Data to Deliver the Future of HealthcareFaster approvals, more accurate and timely medicines monitoring—all enabled by harmonized, consistent and reliable data—will drive improved patient outcomes.
Latest:
Walmart Expanding Their Efforts to Care for HIV CommunityWalmart has opened 70 Specialty Pharmacies of the Community locations across the U.S. in June, and is expected to open 80 more in 11 states by the end of the year.
Latest:
Harnessing Digital at the Point of CareTaking advantage of new advances in tech-driven engagement to boost patient support and adherence
Latest:
Are ADMs a Viable Option for Pharma?The key questions and considerations for drug manufacturers pursuing an effective alternative distribution model.
Latest:
Postponement: A Vital Supply StrategyDrugmakers can turn to postponement, or late-stage customization, to help adapt approaches along the supply chain
Latest:
2023 challenges of the Drug Supply Chain Security Act implementation on wholesale drug distributorsExploring new guidances and future challenges for pharma trading partners in meeting looming DSCSA mandates in the US
Latest:
Navigating Abortion Restrictions Post Dobbs: Considerations for Pharmacy ProvidersAs a result of the United States Supreme Court’s overturning of Roe v. Wade and Planned Parenthood v. Casey, pharmacy providers are looking to state laws and other recently issued federal guidance in determining how they can compliantly meet patient needs and deliver medications.
Latest:
FDA Issues Guidance on Biosimilar LabelingThe draft guidance document discusses the development of labeling for proposed biosimilars and interchangeable biosimilars for submission under section 351(k) of the Public Health Service Act.
Latest:
Transforming the Patient Hub into a Hub of Patient CentricityMethods that pharma companies can use to make the hub more personalized and experiential.
Latest:
The Role and Recruitment of the Chief Patient OfficerNew C-Suite position emerges for more emphasis on patient centricity
Latest:
Ten23 Expands Sterile Manufacturing Capacity at VIVA 1 FacilityFurther expansions of the pharmaceutical development and manufacturing services of ten23 are happening at the BASE and VIVA facilities to continue to support complex sterile product development, testing, and manufacturing.
Latest:
Insights on Insight GatheringUnderstanding markets, influencers, and patients through better stakeholder engagement and faster analysis
Latest:
Beyond the Finish Line: Why Post-Approval Regulatory Strategy MattersIt’s essential for commercial success, but presents its share of obstacles.
Latest:
Getting Unstuck on the Path to Digital TransformationThe transition to AI and machine learning was well underway long before ChatGPT burst onto the marketplace; however, organizations were, and still are, constrained by data challenges.
Latest:
Going Inside the Gross-to-Net Bubble and Its NuancesA crash course on the bubble itself, including therapeutic areas most affected.
Latest:
Reimbursement-Related Analytics and ReportingAn overview of a structural approach that guides development of the analytics and related reporting that may assist brands in gaining or maintaining reimbursement positions and maximizing sales.
Latest:
Enhancing Patient Access and Support Through Technology: A Comprehensive AssessmentWhy the integration of AI-enabled solutions has the potential to boost patient support and engagement across numerous patient care settings.
Latest:
Patient Assistance Programs Pharmacy OptionsChoosing the right pharmacy to administer the program involves a number of factors.
Latest:
In New Year, Resolve to Solve Drug Supply Chain Security Act ComplianceUnder the DSCSA law, wholesale distributors, re-packagers, dispensers, and other third-party logistics providers must implement interoperable and electronic tracing of prescription products at the package level.
Latest:
Operating Without a Commercial Blueprint: Empowering the Field for Niche Therapy LaunchesHow emerging biotech companies can create fruitful partnerships between home office commercial teams and the field force to enable this intelligence gathering, while driving commercial success.
Latest:
Enhancing Patient Access and Support Through Technology: A Comprehensive AssessmentWhy the integration of AI-enabled solutions has the potential to boost patient support and engagement across numerous patient care settings.
Latest:
Making Cold Chain More SustainableHow can pharma manufacturers and distributors balance logistical demands and environmental impact?
Latest:
ESG is Reshaping the Supply ChainSix steps pharma organizations can follow to help achieve sustainability in their product supply chains
Latest:
Disruption without interruption: Transitioning Rare Disease HUB & NCP ProgramsTransitioning a rare disease HUB or NCP program to a rare-focused partner can yield major service quality improvements without program disruption.
Latest:
Rethinking Pharma Commercialization Models as Healthcare EvolvesHow cross-functional commercialization teams can hone their role within clinical management pathways, communicate value to all stakeholders, achieve excellence in evidence generation, and maximize the opportunities of digital technologies
